Zoll Medical receives the FDA approval for new LifeVest model
Zoll Medical Corp received the FDA marketing approval for a new model of its LifeVest wearable defibrillator. The LifeVest is worn by patients who are at a risk of sudden cardiac arrest. Zoll said more than 2,000 patients are currently using the product. The company aims to increase its inventory to support further growth.
-
OrbusNeich Sapphire catheter receives CE Mark approval
Boston receives FDA approval for Taxus Liberte
Boston Scientific gets Japanese approval for heart failure lead
FDA gives unconditional IDE approval to Berlin Heart’s EXCOR
Svelte(TM) Medical Systems, Inc. Receives CE Mark Approval To Market The Svelte Acrobat Stent-On-A-Wire (SOAW) Coronary Stent System
